Robert Hergenrother, Ph.D., joined Southern Research Institute in May 2014 to lead the medical technologies development and commercialization partnership – now AIMTech – between the University of Alabama at Birmingham (UAB) and Southern Research. In October 2014, he was appointed as a professor in the department of biomedical engineering at UAB. Hergenrother has worked in the medical device industry for more than 22 years in research and product development. He has led teams that have launched over 15 new products including neurovascular catheters, guidewires and embolic coils, genomic microarray slides, drug delivery matrices, and coatings for enhanced lubricity of medical devices. Most recently, he led the R&D team at SurModics that encompassed research, engineering, analytical services, and commercial development departments. From 1992 to 1997, Hergenrother served in product development and research roles including Manager of Applied Research, Target Therapeutics – now Stryker Neurovascular.
Hergenrother has participated in multiple licensing and acquisition transactions from both the buy and sell side. He has 18 issued U.S. patents, 9 published U.S. patent applications, and more than 20 scientific publications. He has served on the Industrial Advisory Board for the Biomedical Engineering Department at the University of Minnesota. Hergenrother holds a doctorate and bachelor’s of science in chemical engineering from the University of Wisconsin and the University of Notre Dame, respectively.